"Building on Lilly's legacy of innovation in insulin therapy, once-weekly efsitora may offer a significant advancement for people with type 2 diabetes who need insulin by eliminating over 300 ...

Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week dosing regimen for people living with type 2 diabetes Efsitora was equally safe and effective among adults naïve to ...

In 1993, the Diabetes Control and Complications Trial (DCCT) definitively showed that achieving and maintaining glucose values as close to normal as possible in people with type 1 diabetes will ...

Insulin resistance affects millions of people worldwide, yet many don’t realize their bodies are struggling to process blood sugar effectively until more serious health issues develop. This metabolic ...

By Hugo Francisco de Souza A new study shows that gut microbiome signatures, analyzed through advanced machine learning, can help identify individuals with more severe insulin resistance, offering ...

Protein intake influences far more than muscle mass; it shapes vascular function and pancreatic insulin dynamics over time.